Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Lung Cancer

Only Fools and Horses star Patrick Murray announces he is ‘cured’ of lung cancer

The actor, who played hapless spiv Mickey Pearce, shared an update on Twitter.

The Independent UK

Only Fools And Horses star Patrick Murray reveals his lung cancer is ‘cured’

Only Fools and Horses star Patrick Murray has said his lung cancer is cured and has thanked Sir David Jason for his support.

Evening Standard

Only Fools and Horses star Patrick Murray has an update for fans after cancer treatment

Patrick Murray said his cancer was 'cured'

Wales Online

From analysis to the latest developments in health,
read the most diverse news in one place.

Only Fools And Horses star Patrick Murray says he is ‘cured’ of lung cancer

Only Fools And Horses actor Patrick Murray underwent surgery earlier this year to remove a cancerous tumour in his lung. Subsequent scans showed another tumour in his liver

Daily Mirror

Woman with terminal lung cancer begs council to fix flat's mould she fears will kill her

Jackie Carr said her aggressive chemotherapy treatments means she has struggled to muster up the strength to fight the council on something she said should have been sorted out years ago

Daily Mirror

Lung cancer screening program could save 10,000 Australians over the next decade

Unlike breast and prostate cancers there is no national screening program to detect lung cancer, so by the time it's picked up it's often too late.

ABC News

Sorrento Starts Mid-Stage Study Of Abivertinib In Prostate Cancer

The FDA has signed off Sorrento Therapeutics Inc's (NASDAQ:SRNE) investigational new drug application (IND) for Abivertinib (Fujovee) for Phase 2 MAVERICK study in metastatic castrate-resistant prostate cancer (mCRPC). The MAVERICK study will be conducted in a partnership with the Prostate Cancer Clinical Trials Consortium and will enroll participants with both abiraterone-naïve and abiraterone-progressing…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Monday headlines: OAP Rangers fan in tears and Sam Heughan in Glasgow

Here are the main headlines on the Daily Record website today.

Daily Record

Bristol Myers' Opdivo+Yervoy Fails To Meet Survival Endpoint In Untreated Urothelial Cancer

Bristol Myers Squibb & Co's (NYSE:BMY) Phase 3 CheckMate -901 trial of Opdivo (nivolumab) plus Yervoy (ipilimumab) in urothelial carcinoma did not meet the primary endpoint of overall survival (OS) at the final analysis. The trial compared Opdivo + Yervoy to standard-of-care chemotherapy as a first-line treatment for unresectable or metastatic urothelial carcinoma…

Benzinga

The lung cancer symptom which appears in your fingers

Finger clubbing can be an early sign of the illness

Liverpool Echo

Lung cancer patients to get new drug which can double life-expectancy

It means people with aggressive lung cancer can see their life expectancy go from two and half to five years

Wales Online

Finger test may reveal early sign of lung cancer

Sufferers might be able to spot a few early symptoms

Wales Online

Telltale lung cancer sign in your fingertips that could lead to early diagnosis

Lung cancer affects thousands of people and their families across the UK every year.

Daily Record

Lantheus Holdings Doses First Patient in Phase 2 Clinical Trial of NM-01 for NSCLC

Lantheus Holdings, Inc. (NASDAQ: LNTH) dosed first patient in a Phase 2 trial evaluating NM-01, its proprietary technetium 99m SPECT imaging agent used to assess PD-L1 expression in cancer cells. NM-01 is being investigated in the Phase 2 PELICAN single-arm trial in non-small cell lung cancer (NSCLC) patients.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Lung cancer symptoms: Telltale sign on your fingertips that could lead to early diagnosis

A simple finger test can help diagnose lung cancer. Here's the telltale sign on your fingertips that could be an early symptom of lung cancer as well as the first steps of treatment

Benzinga

Genentech's Tiragolumab/Tecentriq Fails On Progression Free Survival In PD-L1-High Metastatic Lung Cancer

Genentech, a unit of Roche Holdings AG (OTC: RHHBY), announced results from its Phase 3 SKYSCRAPER-01 study, evaluating tiragolumab in PD-L1-high locally advanced or metastatic non-small cell lung cancer (NSCLC).

Asharq Al-Awsat

Blow to Roche’s Cancer Immunotherapy Prospects as 2nd Trial Fails

Development of a new cancer immunotherapy pioneered by Roche was thrown in doubt on Wednesday when its drug tiragolumab failed to slow the progression of lung cancer in a second trial. In a study, a combination of tiragolumab and Roche's established Tecentriq drug did not reduce the rate of disease…

Evening Standard

Dennis Waterman died after secret lung cancer battle, ex-wife confirms

Dennis Waterman’s second wife Patricia Maynard has paid tribute to the Minder actor who died on Sunday at the age of 74.

Get all your
news in one place.

100’s of premium titles.
One news app.

Daily Mirror

Dennis Waterman died after secret two-year battle with lung cancer, ex-wife confirms

Actor Dennis Waterman, who was best known for his roles in television shows Minder, The Sweeney and New Tricks, died on Sunday afternoon with his fourth wife at his side after a secret two-year battle with lung cancer

Benzinga

Arcus Posts Encouraging Data For Domvanalimab-Based Regimes In Lung Cancer Settings

Arcus Biosciences Inc (NYSE:RCUS) announced results from the third interim analysis of the ongoing Phase 2 ARC-7 study of zimberelimab vs. domvanalimab plus zimberelimab (doublet) vs. domvanalimab plus zimberelimab and etrumadenant (triplet) as a first-line treatment for metastatic non-small cell lung cancer. In this interim analysis, both domvanalimab-containing arms continued to show meaningful…

Chicago Sun-Times

Dear Abby: Lung cancer killed my mother, and rude people keep asking if she smoked

It’s as if they think people with a tobacco habit deserve to die.

Liverpool Echo

Mum told she had a 'trapped nerve' finds out she has lung cancer

Andrea Fenn started suffering with severe shoulder and spine pain

Benzinga

Turning Point Inks Licensing Pact For Gastrointestinal Cancers Candidate

Turning Point Therapeutics Inc (NASDAQ:TPTX) entered into an exclusive license agreement with LaNova Medicines Limited to develop and commercialize LM-302, in the U.S. and the rest of the world, excluding Greater China and South Korea. LM-302 is a novel antibody-drug conjugate (ADC) targeting Claudin18.2, a protein expressed in many gastrointestinal cancers, including gastric, gastroesophageal junction,…

Benzinga

Galera Posts Topline Data From Avasopasem Study In Chemoradiotherapy-Induced Esophagitis

Galera Therapeutics Inc (NASDAQ:GRTX) announced topline results from Phase 2a AESOP trial of avasopasem for severe acute radiation-induced esophagitis in lung cancer patients receiving concurrent chemoradiotherapy. Esophagitis is an early side effect of radiation or chemoradiation, causing pain, difficulties in swallowing with potential malnutrition, and dehydration. The trial enrolled 39 patients with unresectable…

Benzinga

FDA Rejects Junshi - Coherus' Toripalimab For Rare Head & Neck Cancer

The FDA has issued a complete response letter (CRL) to Junshi Biosciences Co Ltd and Coherus BioSciences Inc's (NASDAQ:CHRS) toripalimab application for advanced recurrent or metastatic nasopharyngeal carcinoma (NPC). NPC is a rare tumor of the head and neck which originates in the nasopharynx, located behind the nose and above the back of the throat. The…

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.